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Objective. Rheumatoid arthritis (RA) is a chronic
inflammatory disease that is characterized by hypertro-
phy of the synovial tissue, leukocyte infiltration, angio-
genesis, and ultimately joint destruction. Mucins
(MUCs) are a family of heavily glycosylated proteins
that protect epithelial membranes and are used as
ligands for cell adhesion. MUC gene expression has
been found to be altered in many cancers and inflam-
matory states. This study was undertaken to examine its
expression in synovial tissue (ST) and role in arthritis.
Methods. We performed immunohistochemistry,
Western blotting, and reverse transcriptase–polymerase
chain reaction to determine expression patterns of
MUC1, MUC2, MUC3, and MUC5AC in RA, osteoar-
thritic (OA), and normal human ST.
Results. MUC3 was expressed in synovial lining
cells, macrophages, and fibroblasts. Significantly more
RA (n  12) and OA (n  13) synovial lining cells
expressed MUC3 than did normal synovial lining cells
(n  7) (22% and 24% versus 0.4%, respectively; P <
0.05). Additionally, macrophages in RA and OA ST
expressed significantly more MUC3 than did macro-
phages in normal ST (50% and 51% versus 10%, respec-
tively; P < 0.05). MUC5AC was expressed at low levels
in synovial lining cells, macrophages, and endothelial
cells in RA and OA ST, and was barely expressed in
normal ST. MUC1 and MUC2 proteins were not de-
tected in ST. Messenger RNA (mRNA) for MUC3 and
MUC5AC was detected in ST, and mRNA for MUC3 was
detected in cultured ST fibroblasts.
Conclusion. These data demonstrate up-regulated
MUC expression by ST cells and suggest a novel role of
MUC3 and MUC5AC in the pathogenesis of arthritis.
Synovial inflammation, including infiltration of
monocyte-derived macrophages and lymphocytes into
synovial tissue (ST), is characteristic of the chronic
arthritic diseases rheumatoid arthritis (RA) and, to a
lesser extent, osteoarthritis (OA). RA is also character-
ized by fibroblast proliferation and synovial lining hyper-
plasia (1). Additionally, these RA synovial fibroblasts
display a transformed phenotype and can invade and
destroy adjacent cartilage.
Mucins (MUCs) are a heterogeneous family of
heavily O-glycosylated glycoproteins that are present in
the mucus coating of epithelial surfaces in normal and
neoplastic tissue. There are 18 members of the MUC
family, which are classified as either transmembrane, gel
forming, or soluble, based upon known functions and
protein structural similarities (2). MUC gene expression
is regulated at the transcriptional, translational, and
posttranslational levels. MUCs undergo posttransla-
tional modifications including O-glycosylation, multi-
merization, and proteolytic cleavage (2). MUCs were
originally understood to be produced only by stratified
epithelia, but they are now known to also be expressed
by corneal endothelium, vascular endothelium, immune
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cells such as T and B lymphocytes, and dendritic cells
(3–5).
MUC proteins have been implicated in the
pathogenesis of several disease states. Neoplastic trans-
formation is associated with dysregulated MUC expres-
sion and may be due to alterations of the oligosaccharide
chains (6). It has been suggested that MUC5AC and
genetic variants of MUC3 may be involved in the
pathogenesis of inflammatory bowel diseases (7). Ab-
normalities in MUC3 expression by intestinal epithelium
have been shown in patients with Crohn’s disease (8).
MUC5AC expression coincides with macrophage accu-
mulation in a model of lung inflammation, indicating
that macrophages may induce MUC expression by other
cells (9). Additionally, cytokines have been shown to
up-regulate MUC3 and MUC5AC expression (10).
The transmembrane MUC3 has been shown to
be expressed in small intestine, colon, gall bladder, lung,
breast, and salivary gland tissue. MUC3 exists in a
membrane-bound form containing a transmembrane
region and cytoplasmic tail, and in soluble forms arising
from either alternate splicing of the MUC3 gene or
proteolytic cleavage of the MUC3 protein (11). Addi-
tionally, MUC3 is coded for by 2 genes resulting in 2
different proteins, MUC3A and MUC3B. MUC5AC is
expressed in the lung, stomach, pancreas, gallbladder,
and endocervix. This is the first report to describe the
expression of MUC family members MUC1, MUC2,
MUC3, and MUC5AC in normal and diseased ST.
MATERIALS AND METHODS
Tissue specimens. RA ST and OA ST specimens were
obtained from patients undergoing total joint replacement,
and normal ST specimens were obtained at autopsy, shortly
after death. A total of 70 tissue specimens were obtained, 30
from patients with RA (mean age 59.2 years), 25 from patients
with OA (mean age 64.5 years), and 15 from autopsy subjects
(mean age 61.5 years). Seventy-nine percent of the subjects
were women. ST specimens were either frozen for cryostat
sectioning and RNA purification or used fresh for isolation of
synovial fibroblasts. While the majority of the arthritic tissue
specimens were obtained from knee surgeries (79%), tissue
specimens from hip, hand, and ankle surgeries were also
included. All specimens were obtained with Institutional Re-
view Board approval.
Immunohistochemistry. Four-micrometer sections of
ST were immunostained using Elite ABC Kits (Vector, Bur-
lingame, CA). Acetone-fixed slides were blocked with diluted
serum and incubated with monoclonal antibodies (mAb) to
either anti-human MUC1, MUC2, MUC3, or MUC5AC (Lab-
Vision, Fremont, CA), or an isotype-specific IgG control
(Beckman Coulter, Fullerton, CA). Slides were counterstained
with hematoxylin. ST components, including lining cells and
sublining cells (macrophages, lymphocytes, fibroblasts, smooth
muscle cells, and endothelial cells), were graded for immuno-
staining above background by a frequency of staining scale,
scored 0–100%, where 0% indicates no staining and 100%
indicates that all cells were immunoreactive (12). Five 400
fields were examined per section by a single pathologist (GKH)
who was blinded with regard to ST type. Selected sections were
analyzed by 2 additional observers (MVV and AEK). Sublining
macrophages and endothelial cells were identified by morphol-
ogy, which was confirmed by reactivity with anti-CD11c (Bec-
ton Dickinson, Mountain View, CA) and anti–von Willebrand
factor (Dako, Carpinteria, CA), respectively. Synovial fibro-
blasts and smooth muscle cells were differentiated by location;
spindle cells associated with vascular walls were identified as
smooth muscle cells, and spindle cells in the stroma were
categorized as sublining fibroblasts.
Synovial fibroblasts. Seven RA and 4 OA ST speci-
mens were minced and digested in a solution of Dispase,
collagenase, and DNase (12). Synovial fibroblasts were cul-
tured in RPMI 1640 plus 10% fetal bovine serum plus 0.1%
gentamicin (Gibco BRL, Grand Island, NY). The cells were
used at passage 3 or later, at which time they were a homog-
enous population of fibroblasts verified by vimentin staining
(data not shown).
Polymerase chain reaction (PCR). Total RNA was
prepared from ST or synovial fibroblasts by an acid phenol
method (12). Following DNase treatment, RNA (10 g) was
reverse-transcribed using oligo(dT) primers and Superscript II
RT (Gibco BRL). PCR was performed in a buffer containing
1.5 mM MgCl2, 0.2 M each dNTP, 0.2 M each oligo-
nucleotide primer, and 2.5 units of platinum Taq DNA poly-
merase (Invitrogen, Carlsbad, CA). The thermal cycling con-
ditions were as follows: 30 cycles of 95°C for 30 seconds,
58°C for 1 minute, and 72°C for 1 minute. The oligonucleotide
primers were as follows: for MUC3, 5-CCTCATTGCAAAC-
TTCACTC-3 and 5-AGCCCACATTTTCTGTACTG-3; for
MUC5AC, 5-TACAACAACATCATCACGAGTGCG-3
and 5-CTAGGGTGCTAGGAGCTGTCACAG-3; and for
GAPDH, 5-GAACGGGAAGCTCACTGGCATGGC-3 and
5-TGAGGTCCACCACCCTGTTGCTG-3. Bands were
identified on agarose gels using ethidium bromide.
Western blotting. Synovial fibroblasts were lysed in
lysis buffer containing nonionic detergent and protease inhib-
itors (Complete Mini; Roche Diagnostics, Indianapolis, IN).
Twenty micrograms of protein was subjected to 7.5% sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-
PAGE) followed by transfer to nitrocellulose membranes (12).
Membranes were blocked with 5% nonfat milk followed by
incubation with either anti-MUC3 mAb (1:200; LabVision),
anti-MUC3 polyclonal antibody (pAb) (1:500; Biomeda, Fos-
ter City, CA), or rabbit antiactin (1:1,000; Sigma-Aldrich, St.
Louis, MO) in blocking buffer. Blots were then incubated with
a goat anti-mouse or goat anti-rabbit horseradish peroxidase–
conjugated antibody (1:10,000; Amersham, Piscataway, NJ).
All blots were developed using enhanced chemiluminescence
reagents (Amersham). Bands were detected using a Storm 860
PhosphorImager and quantified using ImageQuant software
(Molecular Dynamics, Sunnyvale, CA).
Immunoprecipitation. ST were homogenized in lysis
buffer and then centrifuged and filtered through a 0.45-m
filter. Four hundred micrograms of protein extract was prein-
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cubated with protein A–Sepharose (Amersham). Following
centrifugation, the supernatant was incubated with anti–
MUC3 pAb (Biomeda) and protein A–Sepharose. The MUC3/
anti–MUC-3/protein A–Sepharose complex was collected,
boiled, separated using SDS-PAGE, and transferred to nitro-
cellulose membranes. Nitrocellulose membranes were pro-
cessed as described above for Western blotting, using anti-
MUC3 mAb (1:200).
Statistical analysis. Data were analyzed using Stu-
dent’s t-test. P values less than 0.05 were considered significant.
RESULTS
MUC expression in arthritic ST, determined by
immunohistochemistry. Monoclonal antibodies against
4 MUC proteins were used to determine their expres-
sion in RA, OA, and normal ST specimens, by immuno-
histochemistry. Immunohistochemical staining of these
tissue specimens revealed that MUC3 and MUC5AC
were expressed mainly by arthritic ST, while MUC1 and
MUC2 were not expressed in ST.
Immunohistochemistry using anti-MUC3 was
performed on ST sections from 12 patients with RA and
13 patients with OA, and on 7 normal specimens. RA
and OA synovial lining cells, macrophages, and, to a
lesser extent, sublining fibroblasts expressed MUC3
protein. In contrast, normal ST expressed little or no
MUC3 (Figure 1A). Approximately equal percentages
of RA and OA ST macrophages were immunopositive
for MUC3 (mean  SEM 50  7.2% and 51  7.5%,
respectively), while only 10% of normal ST macrophages
expressed MUC3. Many of the macrophages were lo-
cated in the perivascular region (Figure 1B). The per-
centages of RA and OA synovial lining cells immuno-
positive for MUC3 were also approximately equal (22 
7.3% and 24  5.8%, respectively) (Figure 1C). Only
0.4% of normal synovial lining cells expressed MUC3.
Smaller percentages of RA and OA synovial fibro-
blasts were immunopositive for MUC3 (4.1  2.4% and
12.9  6.6%, respectively). Virtually no endothelial
cells or lymphocytes (1%) were immunopositive for
MUC3.
Figure 1. Mucin 3 (MUC3) expression, determined by immunohistochemistry, in synovial tissue (ST) specimens from patients with
rheumatoid arthritis (RA) and patients with osteoarthritis (OA), and normal (NL) ST. A, Immunohistochemical localization of MUC3
expression in ST. Bars show the mean and SEM. Lining  lining layer; Macs  sublining macrophages; Fibro  sublining fibroblasts;
Lymph  lymphocytes; Endo  endothelial cells; Smooth  smooth muscle cells. B, MUC3 immunohistochemical staining of RA ST
macrophages (left), OA ST macrophages (right), and IgG, the negative control (inset) (original magnification  100). C, MUC3
immunohistochemical staining of RA synovial lining cells (left), OA synovial lining cells (center), and normal synovial lining cells
(right) (original magnification  100). Insets show higher-magnification views (original magnification  400).
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Immunohistochemistry using anti–MUC5AC was
performed on ST sections from 11 patients with RA and
12 patients with OA, and on 9 normal specimens.
MUC5AC was expressed in small percentages of syno-
vial lining cells, macrophages, and endothelial cells in
RA and OA ST, but was not appreciably expressed in
normal ST, although the difference was not statistically
significant (Figures 2A and B). Immunohistochemistry
using anti-MUC1 and anti-MUC2 showed no expression
of these molecules in arthritic joints (Figures 2C and D).
MUC3 expression in ST, determined by reverse
transcriptase–PCR (RT-PCR). To further validate the
expression of MUC3 in ST, RT-PCR was performed on
ST complementary DNA (cDNA). A specific 233-bp
MUC3 band was amplified from ST from patients with
RA, ST from patients with OA, and normal ST (Figure
3A). Similarly, the same specific band was amplified
from RA synovial fibroblasts from 2 patients, confirming
expression of MUC3 (Figure 3A).
MUC3 expression in ST and fibroblasts, de-
termined by Western blotting. To further confirm
that arthritic ST expresses MUC3 protein, OA ST
protein extract was immunoprecipitated with anti-
MUC3 pAb. The immunoprecipitated extract was
then probed with monoclonal anti-MUC3, revealing
the presence of a 60-kd band (Figure 3B). While this
band was smaller than what would be expected for
the whole glycoprotein, it was consistent with the find-
ings of previous studies, which have shown that MUC3
exhibits different molecular weights in different cell
types (13).
Next, protein extracts from synovial fibroblasts
were subjected to Western blotting using either anti-
MUC3 pAb (results not shown) or monoclonal anti-
MUC3 (Figure 3C). RA and OA, but not normal,
synovial fibroblasts expressed a protein that migrated
identically to the 60-kd band seen in the immunoprecipi-
tation of OA ST.
Figure 2. MUC5AC, MUC1, and MUC2 expression, determined by immunohistochemistry, in ST specimens from patients with RA
and patients with OA, and normal ST. A, Immunohistochemical localization of MUC5AC expression in ST. Bars show the mean and
SEM. B, MUC5AC immunohistochemical staining of OA synovial lining cells (left), normal synovial lining cells (center), and IgG, the
negative control (right) (original magnification  100). Insets show higher-magnification views (original magnification  400). C,
MUC1 immunohistochemical staining of RA ST (left), OA ST (center), and breast tissue (right) (original magnification  100). D,
MUC2 immunohistochemical staining of RA ST (left), OA ST (center), and breast tissue (right). Arrowheads indicate immunopositive
cells (original magnification  100). See Figure 1 for definitions.
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MUC5AC expression in ST, determined by RT-
PCR. To confirm the expression of MUC5AC in ST,
RT-PCR was performed on ST cDNA. A specific MUC-
5AC 274-bp band was amplified from ST from patients
with RA, normal ST, and to a lesser extent, ST from
patients with OA (Figure 3D). RT-PCR was also per-
formed on synovial fibroblasts from 3 patients with RA,
but an appropriate-sized band indicating the expression
of MUC5AC messenger RNA (mRNA) could not be
amplified (Figure 3D).
DISCUSSION
The synovial lining layer consists of fibroblast-
like cells and macrophage-like cells. Additionally, syno-
Figure 3. MUC3 and MUC5AC expression, determined by reverse transcriptase–polymerase chain reaction (RT-PCR) and Western
blotting, in ST specimens from patients with RA, and patients with OA, and normal ST. A, Gel electrophoresis of MUC3 RT-PCR
products, using specific MUC3 oligonucleotide primers with ST cDNA (left) and RA synovial fibroblast cDNA (right). Blots are
representative of experiments with 3 RA, 3 OA, and 2 normal ST samples. Fibrocartilage was used as the negative control (NC). B,
Immunoprecipitation of OA ST with a polyclonal anti-MUC3 antibody and detection with a monoclonal anti-MUC3 antibody,
showing a prominent 60-kd band (arrowhead) (left), and without primary antibody (right). C, Western blot analysis of ST fibroblast
MUC3 protein expression using a monoclonal antibody, showing a specific 60-kd band, compared with actin expression determined
by probing with an antiactin antibody. Blots are representative of experiments with 4 RA, 4 OA, and 3 normal synovial fibroblast
samples. D, Gel electrophoresis of MUC5AC RT-PCR products, using specific MUC5AC oligonucleotide primers with ST cDNA
(left) and RA synovial fibroblast cDNA (right). Blots are representative of experiments with 3 RA, 2 OA, and 2 normal ST samples
and 3 RA ST fibroblasts. See Figure 1 for other definitions.
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vial fibroblasts and macrophages exist in the sublining
ST. Our results indicate that synovial lining cells and
sublining macrophages and endothelial cells express
MUC proteins. MUC3, a membrane-type MUC, is
expressed primarily by synovial lining cells and sublining
macrophages. The sublining macrophages that express
MUC3 tend to be perivascular, suggesting that either
they recently arrived in the synovium from the peri-
pheral blood or they are involved in recruiting other
leukocytes into the ST. Additionally, ST from patients
with RA or OA expresses significantly more MUC3
protein than does normal ST, suggesting a role of MUC3
expression in both RA and OA.
ST expression of MUC3 protein was confirmed
by immunoprecipitation and immunoblotting of a 60-kd
band using 2 different anti-MUC3 antibodies. Western
blotting experiments with anti-MUC3 antibodies veri-
fied that RA and OA synovial fibroblasts, but not
normal synovial fibroblasts, also express a 60-kd protein
band.
To further validate ST MUC3 expression, MUC3
mRNA expression in ST from patients with RA and
patients with OA, and normal ST was investigated by
RT-PCR. Surprisingly, the results of these experiments
indicated similar MUC3 mRNA expression levels in
normal ST and arthritic ST, which differed from the
immunohistochemistry and Western blotting data. This
apparent difference may be due to the way the immu-
nohistochemical studies were analyzed, with results re-
ported as the percentage of cells that showed staining
rather than as the amount of MUC3 protein that was
produced. Thus, one possibility is that the 10% of
macrophages that are immunopositive in normal ST are
responsible for the MUC3 mRNA. Alternatively, MUC3
is known to be regulated at the translational and post-
translational levels (11). Taken together, the RT-PCR
and Western blotting data provide evidence that ST and
synovial fibroblasts express MUC3.
MUC3 has previously been shown to be ex-
pressed by epithelial cells from diverse tissue types, but
this is the first study to show MUC3 expression in either
synovial fibroblasts or synovial macrophages. MUC1,
another transmembrane MUC that was originally
thought to be expressed solely by epithelial cells, has
now been identified in lymphocytes and monocyte-
derived dendritic cells, where it may function in leuko-
cyte migration and cell–cell interactions (3,5). We were
unable to detect MUC1 in ST, although we did detect it
in breast tumor tissue. Thus, MUC3 is the second MUC
family member shown to be expressed by a type of
leukocyte.
We found that MUC5AC, a gel-forming MUC,
was expressed in small percentages of synovial lining
cells, sublining macrophages, and synovial endothelial
cells in patients with RA and OA. RT-PCR data provide
supporting evidence of MUC5AC protein expression by
ST. The amplification of MUC5AC mRNA in normal
ST suggests that MUC5AC may be regulated at the
translational level in ST. We were unable to amplify
MUC5AC from synovial fibroblasts, which was consis-
tent with the results of immunohistochemical analysis.
Another gel-forming MUC, MUC2, was not detectable
in ST by immunohistochemistry.
MUC5AC has previously been shown to be ex-
pressed by epithelia and goblet cells in various organs,
but this is the first study to demonstrate MUC5AC
expression by fibroblasts, macrophages, or endothelial
cells (2). MUC5AC has been shown to activate neutro-
phils on the ocular surface, suggesting a role of MUC-
5AC in neutrophil adherence and activation (14).
In conclusion, we have shown that MUC3 is
expressed in significantly more synovial lining cells and
macrophages in arthritic joints than in normal joints,
suggesting that it has a role in arthritis. Additionally,
MUC5AC was expressed by a fraction of synovial lining
and endothelial cells in arthritic ST. Our findings indi-
cate that MUCs are involved in the pathogenesis of
arthritic diseases, including OA and RA.
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